NCT01716182

Brief Summary

This is a post-marketing, on-label Efficacy, Effectiveness and Safety Study designed in a Multicenter, Randomized, Prospective format. This study compares two spinal fusion procedures, Transacral Interbody Fusion and Transforaminal Lumbar Interbody Fusion (TLIF). Enrollment period will be approximately 12-18 months; each Principal Investigator/Study Center will be expected to enroll up to 20 subjects. The protocol requires approximately 7 subject visits to the study center from screening through the final follow-up visit.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2012

Typical duration for all trials

Geographic Reach
1 country

11 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 24, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 29, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

July 9, 2014

Status Verified

July 1, 2014

Enrollment Period

2.1 years

First QC Date

October 24, 2012

Last Update Submit

July 8, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy

    Efficacy: Fusion of the targeted vertebral bodies (L4-L5-S1 or L5-S1) will be assessed individually at 24 months as determined by Central Radiographic Reviewer's (orthopedic surgeon) interpretation of high resolution Computed Tomography (CT) Scan.

    24 months post-operative

Study Arms (2)

transacral lumbar interbody fusion procedure

transforaminal lumbar interbody fusion procedure (TLIF)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

To be eligible to participate in this study, the subject must meet all of the inclusion criteria and none of the exclusion criteria.

You may qualify if:

  • Male or female subject that is eligible for both study procedures only at the L4-L5-S1 or L5-S1 levels with bilateral pedicle screws;
  • The subject has a diagnosis of one or more of the following conditions at the L4-L5-S1 or L5-S1 levels:
  • Spinal stenosis;
  • Spondylolisthesis;
  • Degenerative Disc Disease (DDD) defined as back pain and/or radicular pain with degeneration of the disc as confirmed by history, physical examination and radiographic studies, either by CT, MRI, plain film, myelography, or discography;
  • Adult 18 years of age or older;
  • The subject has undergone at least 6 consecutive months of Conservative Care Therapy(ies);
  • The subject is able and willing to give written informed consent and to comply with the requirements of this study protocol.

You may not qualify if:

  • Coagulopathy;
  • Bowel disease (e.g. Crohn's, ulcerative colitis);
  • Severe scoliosis (curves \> 60°);
  • Sacral agenesis;
  • Spondylolisthesis greater than Grade 1 at the L4-L5-S1 levels, or greater than Grade 2 at the L5-S1 level;
  • Spinal tumor (or history of sacral tumor);
  • History of fracture at L4, L5 and/or S1 vertebral bodies;
  • The subject has undergone a prior fusion procedure of the lumbar spine;
  • Osteoporosis; or, if the subject is at high risk for development of osteoporosis, further screening to be conducted at Investigator's discretion;
  • For women of childbearing potential, pregnancy at the time of enrollment, or planning to become pregnant during the course of the study;
  • The subject has a history of substance abuse (illegal drugs, prescription drugs, or alcohol) that, in the Investigator's opinion, may interfere with protocol assessments and/or the subject's ability to comply with the protocol;
  • Per the Investigator, the subject is in poor general health or undergoing any concurrent disease process that would place the subject in excessive risk to surgery (e.g. significant circulatory problems, cardiac disease, history of bowel surgery);
  • The subject is participating in another spine study, which, in the opinion of the Investigator, could skew results;
  • The subject is involved in litigation related to their back condition;
  • The subject is contraindicated to receive either study procedure;
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

St. Joseph Heritage Healthcare

Fullerton, California, 92835, United States

Location

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States

Location

Indiana Spine Group

Carmel, Indiana, 46032, United States

Location

Bone and Joint Clinic of Baton Rouge

Baton Rouge, Louisiana, 70808, United States

Location

LSU Health Sciences Center, Department of Neurosurgery

New Orleans, Louisiana, 70112, United States

Location

UMass Medical Center, Department of Neurosurgery

Worcester, Massachusetts, 01655, United States

Location

Cary Orthopaedic Spine Specialists

Cary, North Carolina, 27518, United States

Location

Mayfield Clinic/University of Cincinnati

Cincinnati, Ohio, 45219, United States

Location

University Hospitals Case Medical Center

Cleveland, Ohio, 44106, United States

Location

Brazos Spine

College Station, Texas, 77845, United States

Location

Danville Orthopedic Clinic, Inc.

Danville, Virginia, 24541, United States

Location

MeSH Terms

Conditions

Spinal StenosisSpondylolisthesisIntervertebral Disc Degeneration

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesSpondylolysisSpondylosis

Study Officials

  • David Hart, MD

    University Hospitals Cleveland Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2012

First Posted

October 29, 2012

Study Start

June 1, 2012

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

July 9, 2014

Record last verified: 2014-07

Locations